Cargando…

The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent

Eumycetoma is a debilitating chronic inflammatory fungal infection that exists worldwide but it is endemic in many tropical and subtropical regions. The major causative organism is the fungus Madurella mycetomatis. The current treatment of eumycetoma is suboptimal and characterized by low cure rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elfadil, Hassabelrasoul, Fahal, Ahmed, Kloezen, Wendy, Ahmed, Elhadi M., van de Sande, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358886/ https://www.ncbi.nlm.nih.gov/pubmed/25768115 http://dx.doi.org/10.1371/journal.pntd.0003488

Ejemplares similares

Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020)

Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Madurella mycetomatis Is Highly Susceptible to Ravuconazole
por: Ahmed, Sarah Abdalla, et al.
Publicado: (2014)

A Madurella mycetomatis Grain Model in Galleria mellonella Larvae
por: Kloezen, Wendy, et al.
Publicado: (2015)

Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects
por: Elkheir, Lamis Y. M., et al.
Publicado: (2020)

The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection
por: Mhmoud, Najwa A., et al.
Publicado: (2014)

Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

A Histopathological Exploration of the Madurella mycetomatis Grain
por: Ibrahim, Anahid Izzat, et al.
Publicado: (2013)

Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients
por: Nasr, Amre, et al.
Publicado: (2016)

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma
por: Konings, Mickey, et al.
Publicado: (2021)

Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge
por: Sampaio, Felipe Maurício Soeiro, et al.
Publicado: (2013)

Pulmonary Madurella mycetomatis mycetoma secondary to knee eumycetoma, Senegal
por: Diongue, Khadim, et al.
Publicado: (2021)

Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan
por: Litvintseva, Anastasia P., et al.
Publicado: (2022)

The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo
por: Konings, Mickey, et al.
Publicado: (2023)

Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae
por: Sheehan, Gerard, et al.
Publicado: (2020)

Madurella real-time PCR, a novel approach for eumycetoma diagnosis
por: Arastehfar, Amir, et al.
Publicado: (2020)

The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach
por: Lim, Wilson, et al.
Publicado: (2020)

Specific and sensitive loop-mediated isothermal amplification (LAMP) method for Madurella strains, eumycetoma filamentous fungi causative agent
por: Yoshioka, Isato, et al.
Publicado: (2023)

S6.5b Genomics and metagenomics of Madurella mycetomatis
por: Litvintseva, Anastasia, et al.
Publicado: (2022)

Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Peripheral Blood Mononuclear Cells of Mycetoma Patients React Differently to Madurella mycetomatis Antigens than Healthy Endemic Controls
por: Elagab, Ehab A. M., et al.
Publicado: (2013)

Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan
por: Smit, Sandra, et al.
Publicado: (2016)

Draft Genome Sequences of Three Clinical Isolates of Madurella mycetomatis, the Major Cause of Black-Grain Mycetoma
por: Khidir, El Shiekh, et al.
Publicado: (2020)

A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study
por: Verwer, Patricia E. B., et al.
Publicado: (2015)

Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella
por: Lim, Wilson, et al.
Publicado: (2022)

Mycetoma due to Madurella mycetomatis
por: Sigera, L.S.M., et al.
Publicado: (2020)

Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge
por: Scolding, Peter S., et al.
Publicado: (2016)

Rapid Identification of Black Grain Eumycetoma Causative Agents Using Rolling Circle Amplification
por: Ahmed, Sarah A., et al.
Publicado: (2014)

In vitro susceptibility testing for black grain eumycetoma causative agents
por: van de Sande, Wendy W J
Publicado: (2021)

An update on the development of novel antifungal agents for eumycetoma
por: Chandler, David J., et al.
Publicado: (2023)

Phylogenetic Analysis of the Complete Mitochondrial Genome of Madurella mycetomatis Confirms Its Taxonomic Position within the Order Sordariales
por: van de Sande, Wendy W. J.
Publicado: (2012)

Canine eumycetoma caused by Madurella pseudomycetomatis
por: Albanese, Francesco, et al.
Publicado: (2022)

Metagenomic detection of eumycetoma causative agents from households of patients residing in two Sudanese endemic villages in White Nile State
por: Santona, Antonella, et al.
Publicado: (2022)

S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis
por: Abd Algaffar, S. O., et al.
Publicado: (2021)

Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis
por: Bonifaz, Alexandro, et al.
Publicado: (2017)

Association of Eumycetoma and Schistosomiasis
por: van Hellemond, Jaap J., et al.
Publicado: (2013)

Madurella Mycetomatis Infection Following Allogenic Stem Cell Transplantation for Aplastic Anemia
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2012)

Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report
por: Mekoguem, Carine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vss0ib00bend4tav0imjfu0tg6